The most important feature of this study was the establishment of a three-gene prognostic signature based on three AQP1 DNA methylation-associated genes, which may realize a robust and specific risk stratification for elderly CN-AML patients. The gene discussed is AQP1; the disease is acute myeloid leukemia.